Mal-(CH2)5-Val-Cit-PAB-Eribulin

Mal-(CH2)5-Val-Cit-PAB-Eribulin


Mal-(CH2)5-Val-Cit-PAB-Eribulin is an agent-linker conjugate designed for antibody-drug conjugates (ADCs) and demonstrates robust antitumor activity. It incorporates the anti-microtubule agent Eribulin, which is employed in the study of metastatic breast cancer.

Molecular structure of the compound BP-41452
    • Unit
    • Price
    • Qty
    • 5 MG
    • $850.00
    • 10 MG
    • $1550.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire